Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $154.29 | 6 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABIOMED | $83.58 | 2 | $0 (2020) |
| Abbott Laboratories | $40.13 | 2 | $0 (2020) |
| Medtronic Vascular, Inc. | $19.99 | 1 | $0 (2019) |
| Janssen Pharmaceuticals, Inc | $10.59 | 1 | $0 (2017) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2020 | $51.31 | 3 | Abbott Laboratories ($40.13) |
| 2019 | $92.39 | 2 | ABIOMED ($72.40) |
| 2017 | $10.59 | 1 | Janssen Pharmaceuticals, Inc ($10.59) |
All Payment Transactions
6 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/11/2020 | ABIOMED | Impella (Device) | Food and Beverage | In-kind items and services | $11.18 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 09/19/2020 | Abbott Laboratories | Ensite Cardiac Mapping System (Device) | Food and Beverage | In-kind items and services | $26.94 | General |
| Category: Cardiac Arrhythmias and Heart Failure | ||||||
| 09/19/2020 | Abbott Laboratories | Ensite Cardiac Mapping System (Device) | Food and Beverage | In-kind items and services | $13.19 | General |
| Category: Cardiac Arrhythmias and Heart Failure | ||||||
| 09/19/2019 | Medtronic Vascular, Inc. | Azure (Device) | Food and Beverage | In-kind items and services | $19.99 | General |
| Category: Pacemakers | ||||||
| 09/05/2019 | ABIOMED | Impella (Device) | Food and Beverage | In-kind items and services | $72.40 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 06/02/2017 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $10.59 | General |
| Category: Cardiovascular & Metabolism | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 20 | 1,753 | 2,175 | $376,991 | $123,128 |
| 2021 | 14 | 841 | 1,026 | $316,008 | $67,858 |
| 2020 | 32 | 3,886 | 5,966 | $1.7M | $427,561 |
All Medicare Procedures & Services
66 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 138 | 261 | $73,080 | $27,137 | 37.1% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Facility | 2023 | 378 | 386 | $70,252 | $20,309 | 28.9% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 120 | 120 | $43,200 | $14,129 | 32.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 123 | 192 | $38,016 | $14,027 | 36.9% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 81 | 172 | $25,284 | $11,096 | 43.9% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 55 | 57 | $23,256 | $7,620 | 32.8% |
| 93458 | Insertion of tube in left lower heart chamber and coronary artery for diagnosis with review by radiologist | Facility | 2023 | 34 | 34 | $30,770 | $6,769 | 22.0% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 57 | 60 | $16,680 | $6,103 | 36.6% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 27 | 58 | $12,238 | $5,628 | 46.0% |
| 93010 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | Facility | 2023 | 297 | 357 | $6,426 | $2,327 | 36.2% |
| 93454 | Insertion of tube in coronary artery for diagnosis with review by radiologist | Facility | 2023 | 12 | 12 | $8,892 | $1,849 | 20.8% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 143 | 168 | $7,727 | $1,835 | 23.7% |
| 93018 | Exercise or drug-induced heart stress test with electrocardiogram (ecg) with review by physician | Facility | 2023 | 110 | 114 | $4,332 | $1,222 | 28.2% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 14 | 14 | $3,416 | $1,151 | 33.7% |
| 93308 | Ultrasound of heart, follow-up | Facility | 2023 | 30 | 32 | $2,080 | $629.61 | 30.3% |
| 99152 | Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | Facility | 2023 | 40 | 41 | $8,282 | $406.72 | 4.9% |
| 93272 | Electrocardiogram (ecg) up to 30 days continuous with symptom monitoring, transmission and review and report by health care professional | Facility | 2023 | 21 | 21 | $1,337 | $394.80 | 29.5% |
| 93244 | Heart rhythm review, and interpretation of continous external ekg over more than 48 hours up to 7 days | Facility | 2023 | 13 | 13 | $832.00 | $249.47 | 30.0% |
| 93321 | Ultrasound of heart blood flow, valves and chambers, follow-up | Facility | 2023 | 28 | 29 | $551.00 | $162.12 | 29.4% |
| 93325 | Ultrasound of heart with color-depicted blood flow, rate and valve function | Facility | 2023 | 32 | 34 | $340.00 | $83.49 | 24.6% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 256 | 286 | $96,954 | $19,004 | 19.6% |
| 78452 | Nuclear medicine study of vessels of heart using drugs or exercise multiple studies | Office | 2021 | 42 | 42 | $55,902 | $14,535 | 26.0% |
| A9500 | Technetium tc-99m sestamibi, diagnostic, per study dose | Office | 2021 | 42 | 81 | $21,870 | $7,764 | 35.5% |
| J2785 | Injection, regadenoson, 0.1 mg | Office | 2021 | 35 | 134 | $21,153 | $6,365 | 30.1% |
| 93306 | Ultrasound examination of heart including color-depicted blood flow rate, direction, and valve function | Facility | 2021 | 88 | 88 | $20,436 | $4,958 | 24.3% |
About Dr. Alaeddin Ayyad, MD
Dr. Alaeddin Ayyad, MD is a Interventional Cardiology healthcare provider based in Redding, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/15/2008. The National Provider Identifier (NPI) number assigned to this provider is 1548434046.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Alaeddin Ayyad, MD has received a total of $154.29 in payments from pharmaceutical and medical device companies, with $51.31 received in 2020. These payments were reported across 6 transactions from 4 companies. The most common payment nature is "Food and Beverage" ($154.29).
As a Medicare-enrolled provider, Ayyad has provided services to 6,480 Medicare beneficiaries, totaling 9,167 services with total Medicare billing of $618,547. Data is available for 3 years (2020–2023), covering 66 distinct procedure/service records.
Practice Information
- Specialty Interventional Cardiology
- Location Redding, CA
- Active Since 04/15/2008
- Last Updated 08/09/2018
- Taxonomy Code 207RI0011X
- Entity Type Individual
- NPI Number 1548434046
Products in Payments
- Impella (Device) $83.58
- Ensite Cardiac Mapping System (Device) $40.13
- Azure (Device) $19.99
- XARELTO (Drug) $10.59
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Interventional Cardiology Doctors in Redding
Mohamed Khan, M.d, M.D
Interventional Cardiology — Payments: $83,452
Dr. Emmanuel Papadakis, M.d, M.D
Interventional Cardiology — Payments: $14,970
Omar Mufti, Md, MD
Interventional Cardiology — Payments: $5,569
Dr. Bruce Miller, M.d, M.D
Interventional Cardiology — Payments: $908.05